Latham & Watkins Advises on Ardent Health’s Secondary Offering
Ardent Health, Inc. (NYSE: ARDT) has announced the pricing of the previously announced secondary public offering (the Offering) of 8,000,000 shares of its common stock, consisting of 7,136,719 shares of its common stock by an affiliate of Equity Group Investments and 863,281 shares of its common stock by an affiliate of Ventas, Inc. (together, the Selling Stockholders) at a price to the public of US$14.50 per share. In connection with the Offering, the Selling Stockholders granted the underwriters a 30-day option to purchase up to an additional 1,200,000 shares of common stock at the public offering price, less the underwriting discounts and commissions. The Offering is expected to close on November 19, 2026, subject to customary closing conditions.
Latham & Watkins LLP represents the underwriters in the offering with a Capital Markets team led by New York partners Nathan Ajiashvili and Erika Weinberg and New York counsel Lindsey Mills, with associates Matthew Dwelle and Renad Alqarni.